Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

T J Barber^{1

2}, A Imaz³, M Boffito^{4

5}, J Niubó³, A Pozniak⁴, R Fortuny³, J Alonso⁶, N Davies^{4

5}, S Mandalia^{4

5}, D Podzamczer³, B Gazzard^{4

5}

Affiliations

¹ Chelsea and Westminster NHS Foundation Trust and St Stephen's AIDS Trust 4th Floor, St Stephen's Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. t.barber@nhs.net.
² Imperial College London, London, UK. t.barber@nhs.net.
³ Bellvitge University Hospital, Barcelona, Spain.
⁴ Chelsea and Westminster NHS Foundation Trust and St Stephen's AIDS Trust 4th Floor, St Stephen's Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.
⁵ Imperial College London, London, UK.
⁶ Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Published Erratum

T J Barber et al. J Neurovirol. 2018 Jun.

. 2018 Jun;24(3):388-389.

doi: 10.1007/s13365-017-0613-1.

T J Barber^{1

2}, A Imaz³, M Boffito^{4

5}, J Niubó³, A Pozniak⁴, R Fortuny³, J Alonso⁶, N Davies^{4

5}, S Mandalia^{4

5}, D Podzamczer³, B Gazzard^{4

5}

¹ Chelsea and Westminster NHS Foundation Trust and St Stephen's AIDS Trust 4th Floor, St Stephen's Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK. t.barber@nhs.net.
² Imperial College London, London, UK. t.barber@nhs.net.
³ Bellvitge University Hospital, Barcelona, Spain.
⁴ Chelsea and Westminster NHS Foundation Trust and St Stephen's AIDS Trust 4th Floor, St Stephen's Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.
⁵ Imperial College London, London, UK.
⁶ Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Abstract

Due to a production error the bottom portion of Figure 1 was omitted. The corrected figure is given below.

CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.
Barber TJ, Imaz A, Boffito M, Niubó J, Pozniak A, Fortuny R, Alonso J, Davies N, Mandalia S, Podzamczer D, Gazzard B. Barber TJ, et al. J Neurovirol. 2018 Feb;24(1):98-105. doi: 10.1007/s13365-017-0600-6. Epub 2017 Dec 26. J Neurovirol. 2018. PMID: 29280108 Clinical Trial.